Ira Spector net worth
Quick answer
Ira Spector's estimated net worth is $15.0M (range $10.5M – $22.5M) as of 2026. Ira Spector is Founder at SFA Therapeutics. SFA Therapeutics valuation.
Ira Spector is Founder at SFA Therapeutics (YC S21). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: PhD from University of California, Berkeley
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 4
- Website: https://sfatherapeutics.com/
Who is Ira Spector?
Ira Spector is a co-founder of SFA Therapeutics, a company focused on developing therapies for various health conditions.
Highlights:
- University of California, Berkeley
- Y Combinator S21
About SFA Therapeutics
SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a...
FAQ: Ira Spector net worth and SFA Therapeutics valuation
What is Ira Spector's net worth?
Ira Spector's estimated net worth is $15.0M (range $10.5M – $22.5M) as of 2026. Ira Spector is Founder at SFA Therapeutics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is SFA Therapeutics valuation?
SFA Therapeutics's estimated valuation on Entrepreneurial Check is $45.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Ira Spector's role?
Ira Spector is Founder at SFA Therapeutics, a Y Combinator-backed startup (batch S21).